To examine the expression of CDO1 in primary cancer, we performed qRT-PCR analysis with cDNAs derived from patients with colon, breast, esophagus, bladder and stomach cancer (T, n = 1 for each tumor) and patients without cancer (NN, n = 1 for each normal). This evidence concerns the gene CDO1 and neoplasm.